Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $3.94 Million - $4.29 Million
39,322 Added 965.67%
43,394 $4.73 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $419,212 - $465,551
-4,072 Reduced 50.0%
4,072 $419,000
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $884,519 - $964,086
8,144 New
8,144 $939,000
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $838,343 - $935,419
8,144 New
8,144 $866,000
Q3 2022

Nov 18, 2022

BUY
$84.53 - $94.96 $344,206 - $386,677
4,072 New
4,072 $351,000
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $11,187 - $12,681
-134 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $9,850 - $11,041
134 New
134 $11,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Power Corp Of Canada Portfolio

Follow Power Corp Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Power Corp Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Power Corp Of Canada with notifications on news.